KeyBanc Capital Markets initiated coverage on Eastman Chemical EMN with a Buy rating and a $74 price target.
KeyBanc Capital Markets said, "We continue to favor investment stories within the chemical sector that have made meaningful portfolio changes over the years to move into more “specialty businesses,” supporting steady earnings growth and improved margins profiles. We believe a series of acquisitions and divestitures have positioned EMN to post steadier earnings growth through 2015E. We see a good finish to 2012E and EMN's Investor Day on December 12, 2012 as near-term catalysts for the stock as the long-term growth potential for the new EMN is unveiled."
Eastman Chemical closed at $60.05 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in